Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s mouse model
Se Hoon Choi,Enjana Bylykbashi,Zena K Chatila,Star W Lee,Benjamin Pulli,Gregory D Clemenson,Eunhee Kim,Alexander Rompala,Mary K Oram,Caroline Asselin,Jenna Aronson,Can Zhang,Sean J Miller,Andrea Lesinski,John W Chen,Doo Yeon Kim,Henriette van Praag,Bruce M Spiegelman,Fred H Gage,Rudolph E Tanzi,Zena K. Chatila,Star W. Lee,Gregory D. Clemenson,Mary K. Oram,Sean J. Miller,John W. Chen,Bruce M. Spiegelman,Fred H. Gage,Rudolph E. Tanzi
DOI: https://doi.org/10.1126/science.aan8821
IF: 56.9
2018-09-07
Science
Abstract:Adult neurogenesis and Alzheimer's disease Alzheimer's disease (AD) pathology destroys neurons and synapses in the brain, leading to dementia. The brain generates new neurons throughout life in the hippocampus, a process called adult hippocampal neurogenesis (AHN). Choi et al. found that blocking AHN exacerbated cognitive impairment in an AD mouse model (see the Perspective by Spires-Jones and Ritchie). Inducing neurogenesis alone did not improve cognition in AD mice, whereas inducing neurogenesis while simultaneously ameliorating the neuronal environment via exercise did. The use of genetic or pharmacological treatments that simultaneously induced neurogenesis and increased levels of brain-derived neurotrophic factor (BDNF) mimicked the benefits of exercise on cognition. Thus, inducing both neurogenesis and providing BDNF may be useful as an AD therapeutic. Science , this issue p. eaan8821 ; see also p. 975
multidisciplinary sciences